Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Nicholas Shackel"'
Autor:
Anh Le Tuan Nguyen, Lei Si, John S Lubel, Nicholas Shackel, Kwang Chien Yee, Mark Wilson, Jane Bradshaw, Kerry Hardy, Andrew John Palmer, Christopher Leigh Blizzard, Barbara de Graaff
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Hepatocellular carcinoma (HCC) is the fastest increasing cause of cancer death in Australia. A recent Australian consensus guidelines recommended HCC surveillance for cirrhotic patients and non-cirrhotic chronic hepatitis B (CHB)
Externí odkaz:
https://doaj.org/article/88c307713f7e441c97586d9ef824669d
Autor:
Ashika D. Maharaj, John Lubel, Eileen Lam, Paul J. Clark, Oliver Duncan, Jacob George, Gary P. Jeffrey, Lara Lipton, Howard Liu, Geoffrey McCaughan, Eu‐Ling Neo, Jennifer Philip, Simone I. Strasser, Katherine Stuart, Alexander Thompson, Jonathan Tibballs, Thomas Tu, Michael C. Wallace, Alan Wigg, Marnie Wood, Amany Zekry, Elysia Greenhill, Liane J. Ioannou, Golo Ahlenstiel, Kaye Bowers, Stephen J. Clarke, Anouk Dev, Michael Fink, Mark Goodwin, Christos S. Karapetis, Miriam T. Levy, Kate Muller, James O'Beirne, David Pryor, James Seow, Nicholas Shackel, Caroline Tallis, Nick Butler, John K. Olynyk, Kate Reed‐Cox, John R. Zalcberg, Stuart K. Roberts
Publikováno v:
Hepatology Communications, Vol 6, Iss 11, Pp 3260-3271 (2022)
Abstract Although there are several established international guidelines on the management of hepatocellular carcinoma (HCC), there is limited information detailing specific indicators of good quality care. The aim of this study was to develop a core
Externí odkaz:
https://doaj.org/article/9a7c14322e6647adba6c1e30e2bfeb06
Autor:
Anna J. Lomax, Jennifer Lim, Robert Cheng, Arianne Sweeting, Patricia Lowe, Neil McGill, Nicholas Shackel, Elizabeth L. Chua, Catriona McNeil
Publikováno v:
Journal of Skin Cancer, Vol 2018 (2018)
Immune checkpoint inhibitors (anti-PD-1 and anti-CTLA-4 antibodies) are a standard of care for advanced melanoma. Novel toxicities comprise immune-related adverse events (irAE). With increasing use, irAE require recognition, practical management stra
Externí odkaz:
https://doaj.org/article/6a6c7629b3c04ae4a1a5ce60b738c779
Autor:
William Kemp, Wendy Cheng, Katherine A. Stuart, Lauren Beswick, Amanda Nicoll, Richard Skoien, Siddharth Sood, Daniel Croagh, Hugh Gao, Andrew J. Metz, Ammar Majeed, Marie Sinclair, Eric Y. Lee, Avik Majumdar, Alexander J. Thompson, Simon Edmunds, Joanne Mitchell, Stuart K. Roberts, Nicholas Shackel, Kate Muller, Neomal S. Sandanayake, Alicia Braund, Martin Weltman, Philip I. Craig, Gerry MacQuillan, Edmund Tse, Stephen M. Riordan, Anouk Dev
Publikováno v:
Liver International. 41:2934-2943
BACKGROUND AND AIMS: IgG4 sclerosing cholangitis (IgG4-SC) is the biliary component of the multisystem IgG4-related disease. We aimed to investigate the clinical features, demographics, treatment response and outcomes of IgG4-SC in a large Australian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac749ea883fac83a1d2f39aee97a1565
https://doi.org/10.1111/liv.15036
https://doi.org/10.1111/liv.15036
Autor:
Nicholas Shackel
Publikováno v:
European Journal for Philosophy of Science. 12
The Nothing from Infinity paradox arises when the combination of two infinitudes of point particles meet in a supertask and disappear. Corral-Villate claims that my arguments for disappearance fail and concedes that this failure also produces an extr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f9a2ed60d989a6c4bb74d6a6750b55e
https://doi.org/10.1007/s13194-022-00463-z
https://doi.org/10.1007/s13194-022-00463-z
Autor:
Nicholas Shackel
Events between which we have no epistemic reason to discriminate have equal epistemic probabilities. Bertrand's chord paradox, however, appears to show this to be false, and thereby poses a general threat to probabilities for continuum sized state sp
Autor:
Nicholas Shackel
How Moore’s open question argument works, insofar as it does, remains a matter of controversy. The author’s purpose here is to construct an open question argument based on a novel interpretation of how Moore’s argument might work. In order to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5ab5c803098ff61e662c7d2fb1b846
Publikováno v:
Pathology. 54:S52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17b9a2160b0885399d8a5d209322fd4d
https://doi.org/10.1016/j.pathol.2021.12.168
https://doi.org/10.1016/j.pathol.2021.12.168
Autor:
Joe, Sasadeusz, Andrew, Grigg, Peter D, Hughes, Seng, Lee Lim, Michaela, Lucas, Geoff, McColl, Sue Anne, McLachlan, Marion G, Peters, Nicholas, Shackel, Monica, Slavin, Vijaya, Sundararajan, Alexander, Thompson, Joseph, Doyle, James, Rickard, Peter, De Cruz, Robert G, Gish, Kumar, Visvanathan
Publikováno v:
Clinics in liver disease. 23(3)
Because of the relatively high prevalence of both hepatitis B infection and various forms of autoimmune inflammatory diseases treated with aggressive immunotherapy, reactivation of hepatitis B occurs in a substantial number of patients. The risk of r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0acaf91d1ac3937898aba7a453c310b8
https://pubmed.ncbi.nlm.nih.gov/31266625
https://pubmed.ncbi.nlm.nih.gov/31266625
Autor:
Joe, Sasadeusz, Andrew, Grigg, Peter D, Hughes, Seng Lee, Lim, Michaela, Lucas, Geoff, McColl, Sue Anne, McLachlan, Marion G, Peters, Nicholas, Shackel, Monica, Slavin, Vijaya, Sundararajan, Alexander, Thompson, Joseph, Doyle, James, Rickard, Peter, De Cruz, Robert G, Gish, Kumar, Visvanathan
Publikováno v:
Clinics in liver disease. 23(3)
Patients with malignancies require chemotherapy and other immunosuppressive therapies for treatment. Because of this immunosuppression, in patients who have ever been exposed to hepatitis B it is possible for reactivation to occur. This reactivation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a85f9cfe273323ddd35169f28583574c
https://pubmed.ncbi.nlm.nih.gov/31266624
https://pubmed.ncbi.nlm.nih.gov/31266624